nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CYP2C8—Colchicine—primary biliary cirrhosis	0.103	0.344	CbGbCtD
Bortezomib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0829	0.276	CbGbCtD
Bortezomib—CYP2C9—Colchicine—primary biliary cirrhosis	0.0721	0.24	CbGbCtD
Bortezomib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0419	0.14	CbGbCtD
Bortezomib—PSMA1—epithelium—primary biliary cirrhosis	0.00792	0.118	CbGeAlD
Bortezomib—PSMD1—smooth muscle tissue—primary biliary cirrhosis	0.00641	0.0954	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—primary biliary cirrhosis	0.00567	0.0845	CbGeAlD
Bortezomib—PSMB5—smooth muscle tissue—primary biliary cirrhosis	0.00498	0.0742	CbGeAlD
Bortezomib—PSMA1—liver—primary biliary cirrhosis	0.00449	0.0668	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—primary biliary cirrhosis	0.00435	0.0648	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—primary biliary cirrhosis	0.00425	0.0633	CbGeAlD
Bortezomib—PSMD1—liver—primary biliary cirrhosis	0.00377	0.0561	CbGeAlD
Bortezomib—PSMD2—liver—primary biliary cirrhosis	0.00334	0.0497	CbGeAlD
Bortezomib—PSMB8—liver—primary biliary cirrhosis	0.00332	0.0494	CbGeAlD
Bortezomib—PSMB5—liver—primary biliary cirrhosis	0.00293	0.0436	CbGeAlD
Bortezomib—PSMB1—liver—primary biliary cirrhosis	0.00256	0.0381	CbGeAlD
Bortezomib—PSMB2—liver—primary biliary cirrhosis	0.0025	0.0372	CbGeAlD
Bortezomib—SLC31A1—liver—primary biliary cirrhosis	0.00216	0.0322	CbGeAlD
Bortezomib—CYP1A1—epithelium—primary biliary cirrhosis	0.0013	0.0193	CbGeAlD
Bortezomib—PTGS1—epithelium—primary biliary cirrhosis	0.00114	0.017	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—primary biliary cirrhosis	0.0011	0.0163	CbGeAlD
Bortezomib—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000953	0.00252	CcSEcCtD
Bortezomib—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000953	0.00252	CcSEcCtD
Bortezomib—Cramp muscle—Colchicine—primary biliary cirrhosis	0.000932	0.00247	CcSEcCtD
Bortezomib—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00093	0.00246	CcSEcCtD
Bortezomib—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00093	0.00246	CcSEcCtD
Bortezomib—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00093	0.00246	CcSEcCtD
Bortezomib—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00093	0.00246	CcSEcCtD
Bortezomib—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.000915	0.00242	CcSEcCtD
Bortezomib—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.000915	0.00242	CcSEcCtD
Bortezomib—Muscular weakness—Colchicine—primary biliary cirrhosis	0.000913	0.00242	CcSEcCtD
Bortezomib—CYP2C19—liver—primary biliary cirrhosis	0.000912	0.0136	CbGeAlD
Bortezomib—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00238	CcSEcCtD
Bortezomib—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00238	CcSEcCtD
Bortezomib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000865	0.00229	CcSEcCtD
Bortezomib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000865	0.00229	CcSEcCtD
Bortezomib—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.000858	0.00227	CcSEcCtD
Bortezomib—Pancytopenia—Colchicine—primary biliary cirrhosis	0.00085	0.00225	CcSEcCtD
Bortezomib—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000849	0.00225	CcSEcCtD
Bortezomib—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000849	0.00225	CcSEcCtD
Bortezomib—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000849	0.00225	CcSEcCtD
Bortezomib—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000849	0.00225	CcSEcCtD
Bortezomib—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00084	0.00223	CcSEcCtD
Bortezomib—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00084	0.00223	CcSEcCtD
Bortezomib—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.000838	0.00222	CcSEcCtD
Bortezomib—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.000838	0.00222	CcSEcCtD
Bortezomib—Neutropenia—Colchicine—primary biliary cirrhosis	0.000837	0.00222	CcSEcCtD
Bortezomib—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000823	0.00218	CcSEcCtD
Bortezomib—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000823	0.00218	CcSEcCtD
Bortezomib—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000804	0.00213	CcSEcCtD
Bortezomib—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000804	0.00213	CcSEcCtD
Bortezomib—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000804	0.00213	CcSEcCtD
Bortezomib—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000804	0.00213	CcSEcCtD
Bortezomib—CYP2C8—liver—primary biliary cirrhosis	0.000796	0.0119	CbGeAlD
Bortezomib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000788	0.00209	CcSEcCtD
Bortezomib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000788	0.00209	CcSEcCtD
Bortezomib—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000783	0.00207	CcSEcCtD
Bortezomib—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000783	0.00207	CcSEcCtD
Bortezomib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000782	0.00207	CcSEcCtD
Bortezomib—Stomatitis—Colchicine—primary biliary cirrhosis	0.000778	0.00206	CcSEcCtD
Bortezomib—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000773	0.00205	CcSEcCtD
Bortezomib—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000773	0.00205	CcSEcCtD
Bortezomib—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000771	0.00204	CcSEcCtD
Bortezomib—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000771	0.00204	CcSEcCtD
Bortezomib—Haematuria—Colchicine—primary biliary cirrhosis	0.000761	0.00201	CcSEcCtD
Bortezomib—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00198	CcSEcCtD
Bortezomib—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00198	CcSEcCtD
Bortezomib—CYP1A2—liver—primary biliary cirrhosis	0.000745	0.0111	CbGeAlD
Bortezomib—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00197	CcSEcCtD
Bortezomib—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00197	CcSEcCtD
Bortezomib—CYP1A1—liver—primary biliary cirrhosis	0.000735	0.0109	CbGeAlD
Bortezomib—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00194	CcSEcCtD
Bortezomib—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00194	CcSEcCtD
Bortezomib—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000732	0.00194	CcSEcCtD
Bortezomib—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000732	0.00194	CcSEcCtD
Bortezomib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000727	0.00193	CcSEcCtD
Bortezomib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000727	0.00193	CcSEcCtD
Bortezomib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000721	0.00191	CcSEcCtD
Bortezomib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000721	0.00191	CcSEcCtD
Bortezomib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000717	0.0019	CcSEcCtD
Bortezomib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000717	0.0019	CcSEcCtD
Bortezomib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000717	0.0019	CcSEcCtD
Bortezomib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000717	0.0019	CcSEcCtD
Bortezomib—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000713	0.00189	CcSEcCtD
Bortezomib—CYP2C9—liver—primary biliary cirrhosis	0.000707	0.0105	CbGeAlD
Bortezomib—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000707	0.00187	CcSEcCtD
Bortezomib—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000707	0.00187	CcSEcCtD
Bortezomib—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000705	0.00187	CcSEcCtD
Bortezomib—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000705	0.00187	CcSEcCtD
Bortezomib—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00186	CcSEcCtD
Bortezomib—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00186	CcSEcCtD
Bortezomib—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00185	CcSEcCtD
Bortezomib—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00185	CcSEcCtD
Bortezomib—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00185	CcSEcCtD
Bortezomib—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000697	0.00185	CcSEcCtD
Bortezomib—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000683	0.00181	CcSEcCtD
Bortezomib—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000683	0.00181	CcSEcCtD
Bortezomib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000678	0.0018	CcSEcCtD
Bortezomib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000678	0.0018	CcSEcCtD
Bortezomib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000676	0.00179	CcSEcCtD
Bortezomib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000676	0.00179	CcSEcCtD
Bortezomib—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000672	0.00178	CcSEcCtD
Bortezomib—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000672	0.00178	CcSEcCtD
Bortezomib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000669	0.00177	CcSEcCtD
Bortezomib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000647	0.00171	CcSEcCtD
Bortezomib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000647	0.00171	CcSEcCtD
Bortezomib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000645	0.00171	CcSEcCtD
Bortezomib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000643	0.0017	CcSEcCtD
Bortezomib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000643	0.0017	CcSEcCtD
Bortezomib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000635	0.00168	CcSEcCtD
Bortezomib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000635	0.00168	CcSEcCtD
Bortezomib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000634	0.00168	CcSEcCtD
Bortezomib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000634	0.00168	CcSEcCtD
Bortezomib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00167	CcSEcCtD
Bortezomib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00167	CcSEcCtD
Bortezomib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000631	0.00167	CcSEcCtD
Bortezomib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000631	0.00167	CcSEcCtD
Bortezomib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000623	0.00165	CcSEcCtD
Bortezomib—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00062	0.00164	CcSEcCtD
Bortezomib—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00062	0.00164	CcSEcCtD
Bortezomib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000601	0.00159	CcSEcCtD
Bortezomib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000601	0.00159	CcSEcCtD
Bortezomib—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.0006	0.00159	CcSEcCtD
Bortezomib—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.0006	0.00159	CcSEcCtD
Bortezomib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000599	0.00159	CcSEcCtD
Bortezomib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000597	0.00158	CcSEcCtD
Bortezomib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000597	0.00158	CcSEcCtD
Bortezomib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000584	0.00155	CcSEcCtD
Bortezomib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000584	0.00155	CcSEcCtD
Bortezomib—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000581	0.00154	CcSEcCtD
Bortezomib—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000581	0.00154	CcSEcCtD
Bortezomib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00058	0.00154	CcSEcCtD
Bortezomib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00058	0.00154	CcSEcCtD
Bortezomib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00153	CcSEcCtD
Bortezomib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00153	CcSEcCtD
Bortezomib—Anaemia—Colchicine—primary biliary cirrhosis	0.000576	0.00153	CcSEcCtD
Bortezomib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000575	0.00152	CcSEcCtD
Bortezomib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000575	0.00152	CcSEcCtD
Bortezomib—Angioedema—Colchicine—primary biliary cirrhosis	0.00057	0.00151	CcSEcCtD
Bortezomib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00148	CcSEcCtD
Bortezomib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00056	0.00148	CcSEcCtD
Bortezomib—Leukopenia—Colchicine—primary biliary cirrhosis	0.000558	0.00148	CcSEcCtD
Bortezomib—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000552	0.00146	CcSEcCtD
Bortezomib—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000552	0.00146	CcSEcCtD
Bortezomib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000542	0.00143	CcSEcCtD
Bortezomib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000542	0.00143	CcSEcCtD
Bortezomib—CYP3A4—liver—primary biliary cirrhosis	0.000539	0.00803	CbGeAlD
Bortezomib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00143	CcSEcCtD
Bortezomib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000538	0.00143	CcSEcCtD
Bortezomib—CYP2D6—liver—primary biliary cirrhosis	0.000531	0.0079	CbGeAlD
Bortezomib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000531	0.00141	CcSEcCtD
Bortezomib—Myalgia—Colchicine—primary biliary cirrhosis	0.000531	0.00141	CcSEcCtD
Bortezomib—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00052	0.00138	CcSEcCtD
Bortezomib—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00052	0.00138	CcSEcCtD
Bortezomib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000518	0.00137	CcSEcCtD
Bortezomib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000518	0.00137	CcSEcCtD
Bortezomib—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00136	CcSEcCtD
Bortezomib—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00136	CcSEcCtD
Bortezomib—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000505	0.00134	CcSEcCtD
Bortezomib—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000505	0.00134	CcSEcCtD
Bortezomib—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000503	0.00133	CcSEcCtD
Bortezomib—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000503	0.00133	CcSEcCtD
Bortezomib—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000502	0.00133	CcSEcCtD
Bortezomib—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000502	0.00133	CcSEcCtD
Bortezomib—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000501	0.00133	CcSEcCtD
Bortezomib—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000501	0.00133	CcSEcCtD
Bortezomib—Shock—Colchicine—primary biliary cirrhosis	0.000501	0.00133	CcSEcCtD
Bortezomib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000499	0.00132	CcSEcCtD
Bortezomib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000498	0.00132	CcSEcCtD
Bortezomib—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000495	0.00131	CcSEcCtD
Bortezomib—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000495	0.00131	CcSEcCtD
Bortezomib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000494	0.00131	CcSEcCtD
Bortezomib—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000492	0.0013	CcSEcCtD
Bortezomib—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000492	0.0013	CcSEcCtD
Bortezomib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000489	0.00129	CcSEcCtD
Bortezomib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000489	0.00129	CcSEcCtD
Bortezomib—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000485	0.00129	CcSEcCtD
Bortezomib—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000485	0.00129	CcSEcCtD
Bortezomib—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000484	0.00128	CcSEcCtD
Bortezomib—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000484	0.00128	CcSEcCtD
Bortezomib—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00126	CcSEcCtD
Bortezomib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00126	CcSEcCtD
Bortezomib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00126	CcSEcCtD
Bortezomib—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00126	CcSEcCtD
Bortezomib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00126	CcSEcCtD
Bortezomib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00126	CcSEcCtD
Bortezomib—Hypotension—Colchicine—primary biliary cirrhosis	0.000475	0.00126	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00125	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000474	0.00125	CcSEcCtD
Bortezomib—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00125	CcSEcCtD
Bortezomib—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00125	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000464	0.00123	CcSEcCtD
Bortezomib—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00122	CcSEcCtD
Bortezomib—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00122	CcSEcCtD
Bortezomib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000457	0.00121	CcSEcCtD
Bortezomib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000457	0.00121	CcSEcCtD
Bortezomib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000454	0.0012	CcSEcCtD
Bortezomib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000454	0.0012	CcSEcCtD
Bortezomib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00119	CcSEcCtD
Bortezomib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00119	CcSEcCtD
Bortezomib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00119	CcSEcCtD
Bortezomib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00119	CcSEcCtD
Bortezomib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00119	CcSEcCtD
Bortezomib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00119	CcSEcCtD
Bortezomib—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00118	CcSEcCtD
Bortezomib—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00118	CcSEcCtD
Bortezomib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00118	CcSEcCtD
Bortezomib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00118	CcSEcCtD
Bortezomib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000442	0.00117	CcSEcCtD
Bortezomib—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00117	CcSEcCtD
Bortezomib—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00117	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000439	0.00116	CcSEcCtD
Bortezomib—Fatigue—Colchicine—primary biliary cirrhosis	0.000439	0.00116	CcSEcCtD
Bortezomib—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000436	0.00115	CcSEcCtD
Bortezomib—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000436	0.00115	CcSEcCtD
Bortezomib—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000427	0.00113	CcSEcCtD
Bortezomib—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000427	0.00113	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000416	0.0011	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000416	0.0011	CcSEcCtD
Bortezomib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000416	0.0011	CcSEcCtD
Bortezomib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00109	CcSEcCtD
Bortezomib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00109	CcSEcCtD
Bortezomib—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00109	CcSEcCtD
Bortezomib—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00109	CcSEcCtD
Bortezomib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000408	0.00108	CcSEcCtD
Bortezomib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000408	0.00108	CcSEcCtD
Bortezomib—Urticaria—Colchicine—primary biliary cirrhosis	0.000404	0.00107	CcSEcCtD
Bortezomib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000402	0.00107	CcSEcCtD
Bortezomib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000402	0.00107	CcSEcCtD
Bortezomib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000402	0.00107	CcSEcCtD
Bortezomib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00105	CcSEcCtD
Bortezomib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000397	0.00105	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000395	0.00105	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000395	0.00105	CcSEcCtD
Bortezomib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00104	CcSEcCtD
Bortezomib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00104	CcSEcCtD
Bortezomib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00104	CcSEcCtD
Bortezomib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00104	CcSEcCtD
Bortezomib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00104	CcSEcCtD
Bortezomib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00104	CcSEcCtD
Bortezomib—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000377	0.000998	CcSEcCtD
Bortezomib—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000377	0.000998	CcSEcCtD
Bortezomib—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000375	0.000993	CcSEcCtD
Bortezomib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00099	CcSEcCtD
Bortezomib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00099	CcSEcCtD
Bortezomib—Asthenia—Colchicine—primary biliary cirrhosis	0.000365	0.000967	CcSEcCtD
Bortezomib—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000363	0.000962	CcSEcCtD
Bortezomib—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000363	0.000962	CcSEcCtD
Bortezomib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000361	0.000957	CcSEcCtD
Bortezomib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000361	0.000957	CcSEcCtD
Bortezomib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000361	0.000957	CcSEcCtD
Bortezomib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000361	0.000957	CcSEcCtD
Bortezomib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000348	0.000922	CcSEcCtD
Bortezomib—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000337	0.000892	CcSEcCtD
Bortezomib—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000337	0.000892	CcSEcCtD
Bortezomib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.000869	CcSEcCtD
Bortezomib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.000869	CcSEcCtD
Bortezomib—Vomiting—Colchicine—primary biliary cirrhosis	0.000323	0.000857	CcSEcCtD
Bortezomib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000323	0.000857	CcSEcCtD
Bortezomib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000323	0.000857	CcSEcCtD
Bortezomib—Rash—Colchicine—primary biliary cirrhosis	0.000321	0.00085	CcSEcCtD
Bortezomib—Dermatitis—Colchicine—primary biliary cirrhosis	0.00032	0.000849	CcSEcCtD
Bortezomib—Headache—Colchicine—primary biliary cirrhosis	0.000319	0.000844	CcSEcCtD
Bortezomib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.000828	CcSEcCtD
Bortezomib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.000828	CcSEcCtD
Bortezomib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000302	0.000801	CcSEcCtD
Bortezomib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000302	0.000801	CcSEcCtD
Bortezomib—Nausea—Colchicine—primary biliary cirrhosis	0.000302	0.0008	CcSEcCtD
Bortezomib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00077	CcSEcCtD
Bortezomib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00077	CcSEcCtD
Bortezomib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000288	0.000763	CcSEcCtD
Bortezomib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000288	0.000763	CcSEcCtD
Bortezomib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000288	0.000763	CcSEcCtD
Bortezomib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000288	0.000763	CcSEcCtD
Bortezomib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000286	0.000758	CcSEcCtD
Bortezomib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000286	0.000758	CcSEcCtD
Bortezomib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000272	0.000719	CcSEcCtD
Bortezomib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000272	0.000719	CcSEcCtD
Bortezomib—PSMD2—Disease—CD80—primary biliary cirrhosis	4.42e-05	0.000173	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PDHX—primary biliary cirrhosis	4.41e-05	0.000173	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	4.36e-05	0.000171	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—AGT—primary biliary cirrhosis	4.22e-05	0.000165	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCL5—primary biliary cirrhosis	4.22e-05	0.000165	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—AGT—primary biliary cirrhosis	4.2e-05	0.000165	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCL5—primary biliary cirrhosis	4.2e-05	0.000165	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—AGT—primary biliary cirrhosis	4.18e-05	0.000164	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCL5—primary biliary cirrhosis	4.18e-05	0.000164	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—DLAT—primary biliary cirrhosis	4.14e-05	0.000162	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ABCB4—primary biliary cirrhosis	4.14e-05	0.000162	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PPARGC1A—primary biliary cirrhosis	4.11e-05	0.000161	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.11e-05	0.000161	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PPARGC1A—primary biliary cirrhosis	4.11e-05	0.000161	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	4.09e-05	0.00016	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.09e-05	0.00016	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—TYK2—primary biliary cirrhosis	4.08e-05	0.00016	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.07e-05	0.000159	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—TYK2—primary biliary cirrhosis	4.06e-05	0.000159	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.05e-05	0.000159	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PPARGC1A—primary biliary cirrhosis	4.05e-05	0.000159	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	4.05e-05	0.000159	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—TYK2—primary biliary cirrhosis	4.04e-05	0.000158	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PDHX—primary biliary cirrhosis	4.04e-05	0.000158	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.97e-05	0.000156	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.97e-05	0.000156	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.97e-05	0.000156	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.92e-05	0.000154	CbGpPWpGaD
Bortezomib—PSMB5—Disease—HIF1A—primary biliary cirrhosis	3.83e-05	0.00015	CbGpPWpGaD
Bortezomib—PSMB1—Disease—HIF1A—primary biliary cirrhosis	3.83e-05	0.00015	CbGpPWpGaD
Bortezomib—PSMB2—Disease—HIF1A—primary biliary cirrhosis	3.83e-05	0.00015	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.82e-05	0.00015	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCB4—primary biliary cirrhosis	3.8e-05	0.000149	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—DLAT—primary biliary cirrhosis	3.8e-05	0.000149	CbGpPWpGaD
Bortezomib—PSMB8—Disease—HIF1A—primary biliary cirrhosis	3.78e-05	0.000148	CbGpPWpGaD
Bortezomib—PSMA1—Disease—TYK2—primary biliary cirrhosis	3.77e-05	0.000148	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.75e-05	0.000147	CbGpPWpGaD
Bortezomib—PSMD1—Disease—TYK2—primary biliary cirrhosis	3.75e-05	0.000147	CbGpPWpGaD
Bortezomib—PSMD2—Disease—TYK2—primary biliary cirrhosis	3.73e-05	0.000146	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	3.72e-05	0.000146	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.71e-05	0.000146	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.71e-05	0.000146	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.71e-05	0.000146	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	3.69e-05	0.000145	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD80—primary biliary cirrhosis	3.66e-05	0.000144	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD80—primary biliary cirrhosis	3.66e-05	0.000144	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD80—primary biliary cirrhosis	3.66e-05	0.000144	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.66e-05	0.000144	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.65e-05	0.000143	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD80—primary biliary cirrhosis	3.61e-05	0.000142	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	3.61e-05	0.000141	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.54e-05	0.000139	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NUP210—primary biliary cirrhosis	3.53e-05	0.000139	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AGT—primary biliary cirrhosis	3.53e-05	0.000138	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.52e-05	0.000138	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AGT—primary biliary cirrhosis	3.51e-05	0.000138	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.51e-05	0.000138	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.5e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AGT—primary biliary cirrhosis	3.49e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NOS2—primary biliary cirrhosis	3.49e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NOS2—primary biliary cirrhosis	3.49e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NOS2—primary biliary cirrhosis	3.49e-05	0.000137	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NOS2—primary biliary cirrhosis	3.44e-05	0.000135	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.4e-05	0.000133	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	3.39e-05	0.000133	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	3.39e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP3—primary biliary cirrhosis	3.39e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP3—primary biliary cirrhosis	3.39e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP3—primary biliary cirrhosis	3.39e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CD80—primary biliary cirrhosis	3.38e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CD80—primary biliary cirrhosis	3.38e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CD80—primary biliary cirrhosis	3.38e-05	0.000133	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	3.37e-05	0.000132	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP3—primary biliary cirrhosis	3.34e-05	0.000131	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CD80—primary biliary cirrhosis	3.33e-05	0.000131	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.33e-05	0.00013	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	3.32e-05	0.00013	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	3.29e-05	0.000129	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ABCG2—primary biliary cirrhosis	3.29e-05	0.000129	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—ALB—primary biliary cirrhosis	3.24e-05	0.000127	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—ALB—primary biliary cirrhosis	3.22e-05	0.000126	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—ALB—primary biliary cirrhosis	3.21e-05	0.000126	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—AGT—primary biliary cirrhosis	3.2e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—AGT—primary biliary cirrhosis	3.2e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—AGT—primary biliary cirrhosis	3.2e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCL5—primary biliary cirrhosis	3.2e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCL5—primary biliary cirrhosis	3.2e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCL5—primary biliary cirrhosis	3.2e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—NFKB1—primary biliary cirrhosis	3.18e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—NFKB1—primary biliary cirrhosis	3.16e-05	0.000124	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	3.15e-05	0.000124	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—AGT—primary biliary cirrhosis	3.15e-05	0.000124	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCL5—primary biliary cirrhosis	3.15e-05	0.000124	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—NFKB1—primary biliary cirrhosis	3.15e-05	0.000123	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CD80—primary biliary cirrhosis	3.13e-05	0.000123	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.12e-05	0.000122	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	3.12e-05	0.000122	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	3.12e-05	0.000122	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.11e-05	0.000122	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CD80—primary biliary cirrhosis	3.11e-05	0.000122	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.1e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.1e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.1e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CD80—primary biliary cirrhosis	3.1e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—TYK2—primary biliary cirrhosis	3.09e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—TYK2—primary biliary cirrhosis	3.09e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—TYK2—primary biliary cirrhosis	3.09e-05	0.000121	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	3.09e-05	0.000121	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	3.09e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.05e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—TYK2—primary biliary cirrhosis	3.05e-05	0.00012	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.88e-05	0.000113	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TYK2—primary biliary cirrhosis	2.86e-05	0.000112	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TYK2—primary biliary cirrhosis	2.86e-05	0.000112	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TYK2—primary biliary cirrhosis	2.86e-05	0.000112	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.85e-05	0.000112	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.84e-05	0.000111	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CTGF—primary biliary cirrhosis	2.82e-05	0.000111	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TYK2—primary biliary cirrhosis	2.82e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	2.81e-05	0.00011	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GOT2—primary biliary cirrhosis	2.79e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.78e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.68e-05	0.000105	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.68e-05	0.000105	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.68e-05	0.000105	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AGT—primary biliary cirrhosis	2.67e-05	0.000105	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AGT—primary biliary cirrhosis	2.67e-05	0.000105	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AGT—primary biliary cirrhosis	2.67e-05	0.000105	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.65e-05	0.000104	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.64e-05	0.000104	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	2.64e-05	0.000104	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	2.64e-05	0.000104	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TYK2—primary biliary cirrhosis	2.64e-05	0.000103	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AGT—primary biliary cirrhosis	2.64e-05	0.000103	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TYK2—primary biliary cirrhosis	2.63e-05	0.000103	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TYK2—primary biliary cirrhosis	2.61e-05	0.000102	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.53e-05	9.93e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NUP210—primary biliary cirrhosis	2.49e-05	9.76e-05	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—ALB—primary biliary cirrhosis	2.45e-05	9.62e-05	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—ALB—primary biliary cirrhosis	2.45e-05	9.62e-05	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—ALB—primary biliary cirrhosis	2.45e-05	9.62e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	2.43e-05	9.54e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.43e-05	9.54e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.42e-05	9.51e-05	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—ALB—primary biliary cirrhosis	2.42e-05	9.48e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GOT1—primary biliary cirrhosis	2.41e-05	9.45e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GGT1—primary biliary cirrhosis	2.41e-05	9.45e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NFKB1—primary biliary cirrhosis	2.41e-05	9.45e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—NFKB1—primary biliary cirrhosis	2.41e-05	9.45e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NFKB1—primary biliary cirrhosis	2.41e-05	9.45e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NFKB1—primary biliary cirrhosis	2.38e-05	9.31e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CD80—primary biliary cirrhosis	2.37e-05	9.29e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CD80—primary biliary cirrhosis	2.37e-05	9.29e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CD80—primary biliary cirrhosis	2.37e-05	9.29e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CD80—primary biliary cirrhosis	2.34e-05	9.15e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ABCG2—primary biliary cirrhosis	2.32e-05	9.08e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	2.28e-05	8.95e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	2.17e-05	8.5e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.17e-05	8.49e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.16e-05	8.48e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PPARGC1A—primary biliary cirrhosis	2.15e-05	8.41e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	2.12e-05	8.32e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.08e-05	8.15e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.07e-05	8.11e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP9—primary biliary cirrhosis	2.06e-05	8.07e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.06e-05	8.06e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.05e-05	8.02e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	2.04e-05	7.99e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	2.04e-05	7.99e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	2.04e-05	7.99e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.04e-05	7.98e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.03e-05	7.96e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TYK2—primary biliary cirrhosis	2e-05	7.84e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TYK2—primary biliary cirrhosis	2e-05	7.84e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TYK2—primary biliary cirrhosis	2e-05	7.84e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CTGF—primary biliary cirrhosis	1.99e-05	7.79e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.97e-05	7.74e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TYK2—primary biliary cirrhosis	1.97e-05	7.73e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GOT2—primary biliary cirrhosis	1.97e-05	7.72e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	1.89e-05	7.43e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1.87e-05	7.35e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.86e-05	7.29e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	1.86e-05	7.28e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	1.82e-05	7.14e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	1.8e-05	7.07e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	1.74e-05	6.83e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	1.73e-05	6.77e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GGT1—primary biliary cirrhosis	1.7e-05	6.66e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GOT1—primary biliary cirrhosis	1.7e-05	6.66e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.69e-05	6.61e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—AGT—primary biliary cirrhosis	1.67e-05	6.55e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.66e-05	6.51e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	1.63e-05	6.37e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	1.61e-05	6.31e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	1.59e-05	6.22e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP9—primary biliary cirrhosis	1.57e-05	6.17e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP9—primary biliary cirrhosis	1.57e-05	6.17e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.57e-05	6.17e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.56e-05	6.11e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.56e-05	6.11e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.56e-05	6.11e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	1.56e-05	6.11e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	1.56e-05	6.11e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP9—primary biliary cirrhosis	1.55e-05	6.09e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.54e-05	6.02e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.51e-05	5.94e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.51e-05	5.93e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	1.5e-05	5.86e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	1.48e-05	5.81e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	1.48e-05	5.81e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	1.48e-05	5.79e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	1.47e-05	5.76e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	1.39e-05	5.45e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	1.39e-05	5.45e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	1.39e-05	5.43e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.29e-05	5.07e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ALB—primary biliary cirrhosis	1.28e-05	5.03e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	1.28e-05	5.01e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	1.28e-05	5.01e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	1.27e-05	4.97e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	1.27e-05	4.97e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	1.27e-05	4.96e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	1.26e-05	4.92e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	1.24e-05	4.85e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.23e-05	4.8e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AGT—primary biliary cirrhosis	1.18e-05	4.62e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.14e-05	4.47e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.14e-05	4.46e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	1.13e-05	4.42e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	1.08e-05	4.25e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	1.08e-05	4.25e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	1.08e-05	4.23e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	9.77e-06	3.83e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	9.69e-06	3.8e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	9.64e-06	3.78e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	9.64e-06	3.78e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALB—primary biliary cirrhosis	9.04e-06	3.54e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	8.87e-06	3.48e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	8.79e-06	3.45e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	8.36e-06	3.28e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	8.36e-06	3.28e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	8.29e-06	3.25e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	7.51e-06	2.94e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	7.44e-06	2.92e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	7.4e-06	2.9e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	6.8e-06	2.67e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	6.74e-06	2.64e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	5.8e-06	2.27e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	5.76e-06	2.26e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	4.45e-06	1.74e-05	CbGpPWpGaD
